Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Methylpiperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CHKA | P35790 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | PHGDH | O43175 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.38 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylpiperazine SCHEMBL27895941 | 0.97 | CA2 (0.39) | CA2CA12CA1CA9CHKA | |
| Methylpiperazine SCHEMBL16669183 | 0.92 | CA2 (0.42) | CA2CA12CA1CA9CHKA | |
| Methylpiperazine SCHEMBL1681596 | 0.90 | CYP1A2 (0.44) | CA2CA12CA1CA9CHKA | |
| Methylpiperazine SCHEMBL8607131 | 0.87 | CA2 (0.39) | CA2CA12CA1CA9CHKA | |
| Methylpiperazine SCHEMBL9400626 | 0.87 | CA2 (0.39) | CA2CA12CA1CA9CHKA | |
| Methylpiperazine SCHEMBL28060474 | 0.87 | CYP1A2 (0.42) | CA2CA12CA1CA9CHKA | |
| Fumaric Acid SCHEMBL7463657 | 0.85 | TSHR (0.43) | CA2CA12CA1CA9CHKA | |
| Maleic Acid SCHEMBL30024098 | 0.85 | TSHR (0.43) | CA2CA12CA1CA9CHKA | |
| Maleic Acid SCHEMBL6625236 | 0.85 | TSHR (0.43) | CA2CA12CA1CA9CHKA | |
| Fumaric Acid SCHEMBL7463662 | 0.85 | TSHR (0.43) | CA2CA12CA1CA9CHKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115243764-B | Heterocyclic derivatives as TRMP antagonists | 奇华顿股份有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-118829416-A | Composition (III) | 西姆莱斯股份公司 | 2024-10-22 | — | — | CN | claimed |
| CN-115243764-A | Heterocyclic derivatives as TRMP8 antagonists | 奇华顿股份有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-115243764-B | Heterocyclic derivatives as TRMP antagonists | 奇华顿股份有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-118829416-A | Composition (III) | 西姆莱斯股份公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-115243764-A | Heterocyclic derivatives as TRMP8 antagonists | 奇华顿股份有限公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-1365359-A | Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists | LILLY CO ELI (US) | 2002-08-21 | — | — | CN | disclosed |
| EP-1204654-A1 | BENZOFURYLPIPERAZINES AND BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS | ELI LILLY AND COMPANY (US) | 2002-05-15 | — | — | EP | disclosed |
| WO-2001009111-A1 | BENZOFURYLPIPERAZINES AND BENZOFURYLHOMOPIPERAZINES: SEROTONIN AGONISTS | ELI LILLY AND COMPANY (US) | 2001-02-08 | — | — | WO | disclosed |
| EP-0593557-A1 | AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY. | MERCK SHARP & DOHME (GB) | 1994-04-27 | — | — | EP | disclosed |